NeuroBo Pharmaceuticals I...

2.36
0.01 (0.43%)
At close: Nov 27, 2024, 9:00 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 28.00K 72.00K 67.00K 17.00K n/a n/a n/a n/a n/a
Gross Profit n/a -28.00K -72.00K -67.00K -17.00K n/a n/a n/a n/a n/a
Operating Income -15.89M -19.63M -15.30M -29.72M -20.18M -22.80M -33.12M -14.70M -8.08M -266.00K
Interest Income 461.00K 2.19K 14.00K 39.00K n/a n/a n/a n/a n/a n/a
Pretax Income -12.47M -13.97M -15.28M -29.68M -21.31M -23.64M -33.41M -14.59M -9.03M -320.00K
Net Income -12.47M -6.12M -15.22M -29.59M -22.43M -23.64M -33.41M -14.59M -9.03M -320.00K
Selling & General & Admin 6.73M 8.64M 8.75M 7.85M 2.70M 8.49M 10.44M 5.96M 3.18M 214.00K
Research & Development 9.16M 2.78M 6.55M 21.87M 17.48M 14.31M 22.69M 8.74M 3.99M 52.00K
Other Expenses n/a -83.00K n/a -1K 12.15M -178.00K 10.44M n/a n/a n/a
Operating Expenses 15.89M 11.42M 15.30M 29.72M 20.18M 22.80M 33.12M 14.70M 7.17M 266.00K
Interest Expense n/a 2.19M n/a 39.00K 22.00K 654.00K n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a 10.38M n/a n/a n/a
Cost & Expenses 15.89M 11.42M 15.30M 29.72M 20.18M 22.80M 33.12M 14.70M 7.17M 266.00K
Income Tax n/a -7.85M -62.00K -85.00K 1.12M 654.00K 286.00K -136.82K -146.00K 55.00K
Shares Outstanding (Basic) 5.07M 321.70K 96.43K 67.57K 21.77K 141.71K 13.80K 7.75K 7.07K 7.07K
Shares Outstanding (Diluted) 5.07M 321.70K 96.43K 67.57K 21.77K 141.71K 13.80K 7.75K 7.07K 7.07K
EPS (Basic) -2.46 -19.01 -157.85 -437.95 -1.03K -166.8 -2.42K -1.88K -1.28K -45.27
EPS (Diluted) -2.46 -19.01 -157.85 -437.95 -1.03K -166.8 -2.42K -1.88K -1.28K -45.27
EBITDA -15.88M -11.40M -15.21M -29.61M -21.17M -15.49M -33.09M -14.50M -6.07M -283.00K
Depreciation & Amortization 7.00K 28.00K 72.00K 67.00K 17.00K 6.67M 60.00K -17.00K 2.01M -1K